These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37660060)

  • 1. Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma.
    Qin H; Abulaiti A; Maimaiti A; Abulaiti Z; Fan G; Aili Y; Ji W; Wang Z; Wang Y
    J Transl Med; 2023 Sep; 21(1):588. PubMed ID: 37660060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer.
    Ma Y; Jin J; Xue Z; Zhao J; Cai W; Zhang W
    J Transl Med; 2024 Apr; 22(1):381. PubMed ID: 38654380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of machine learning for developing a prognostic signature related to programmed cell death in colorectal cancer.
    Xu QT; Qiang JK; Huang ZY; Jiang WJ; Cui XM; Hu RH; Wang T; Yi XL; Li JY; Yu Z; Zhang S; Du T; Liu J; Jiang XH
    Environ Toxicol; 2024 May; 39(5):2908-2926. PubMed ID: 38299230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma.
    Miao Y; Liu J; Liu X; Yuan Q; Li H; Zhang Y; Zhan Y; Feng X
    Front Genet; 2022; 13():951239. PubMed ID: 36186436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the Role of Pyroptosis in Lower-Grade Glioma: Development of a Novel Scoring System to Enhance Personalized Therapeutic Approaches.
    Chen X; Xu Y; Wang M; Ren C
    J Mol Neurosci; 2023 Aug; 73(7-8):649-663. PubMed ID: 37566191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma.
    Han X; Yan Z; Fan K; Guan X; Hu B; Li X; Ou Y; Cui B; An L; Zhang Y; Gong J
    Front Immunol; 2023; 14():1220100. PubMed ID: 37662954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma.
    Li J; Guo Q; Xing R
    BMC Cancer; 2023 Aug; 23(1):727. PubMed ID: 37543576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning-based investigation of regulated cell death for predicting prognosis and immunotherapy response in glioma patients.
    Zhang W; Dang R; Liu H; Dai L; Liu H; Adegboro AA; Zhang Y; Li W; Peng K; Hong J; Li X
    Sci Rep; 2024 Feb; 14(1):4173. PubMed ID: 38378721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
    Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma.
    Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z
    BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma.
    Zhang N; Zhang H; Wu W; Zhou R; Li S; Wang Z; Dai Z; Zhang L; Liu F; Liu Z; Zhang J; Luo P; Liu Z; Cheng Q
    Theranostics; 2022; 12(13):5931-5948. PubMed ID: 35966587
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer.
    Zhu W; Zeng H; Huang J; Wu J; Wang Y; Wang Z; Wang H; Luo Y; Lai W
    J Transl Med; 2023 Nov; 21(1):782. PubMed ID: 37925432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning.
    Liu XP; Jin X; Seyed Ahmadian S; Yang X; Tian SF; Cai YX; Chawla K; Snijders AM; Xia Y; van Diest PJ; Weiss WA; Mao JH; Li ZQ; Vogel H; Chang H
    Neuro Oncol; 2023 Jan; 25(1):68-81. PubMed ID: 35716369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma.
    Cao Y; Zhu H; Chen Q; Huang H; Xie D; Li X; Jiang X; Ren C; Peng J
    Front Pharmacol; 2022; 13():914667. PubMed ID: 36091778
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma.
    Wang X; Huang Y; Li S; Zhang H
    Front Immunol; 2022; 13():1027154. PubMed ID: 36275754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
    Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
    Front Genet; 2022; 13():872186. PubMed ID: 35937991
    [No Abstract]   [Full Text] [Related]  

  • 17. A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma.
    Zhang Y; Wang Y; Chen J; Xia Y; Huang Y
    Front Immunol; 2023; 14():1183230. PubMed ID: 37671155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a prognostic gene expression signature for lower-grade glioma following surgery and adjuvant radiotherapy.
    Qian DC; Marascio JA; Tobillo R; Lorenz JW; McCall NS; Neill SG; Hoang KB; Olson JJ; Eaton BR; Shu HG; Zhong J
    Radiother Oncol; 2022 Oct; 175():93-100. PubMed ID: 35998839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel, effective machine learning-based RNA editing profile for predicting the prognosis of lower-grade gliomas.
    Wang B; Tian P; Sun Q; Zhang H; Han L; Zhu B
    Heliyon; 2023 Jul; 9(7):e18075. PubMed ID: 37483735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma.
    Zhang G; Chen A; Fang J; Wu A; Chen G; Tai P; Chen H; Chen X; Cao K
    Front Immunol; 2023; 14():1105210. PubMed ID: 37114037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.